NYSE:RBOT Vicarious Surgical (RBOT) Stock Price, News & Analysis $0.04 -0.01 (-18.37%) As of 12:52 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Vicarious Surgical Stock (NYSE:RBOT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Vicarious Surgical alerts:Sign Up Key Stats Today's Range$0.04▼$0.0650-Day Range$0.03▼$0.2052-Week Range$0.02▼$7.72Volume65,992 shsAverage Volume66,482 shsMarket Capitalization$284.96 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Vicarious Surgical, Inc. is a medical technology company developing robotic systems for minimally invasive surgery. Its platform is designed to allow surgeons to perform procedures through a small incision using computer-controlled instruments, three-dimensional visualization and an immersive, virtual-reality-style interface. The company’s primary product is the Vicarious Surgical System, which combines a robotic surgical unit with miniature instruments and a high-resolution digital visualization system. The technology is intended to provide surgeons with enhanced visualization and instrument maneuverability while potentially reducing the size and number of incisions required for certain abdominal procedures. Founded in 2014 and headquartered in Waltham, Massachusetts, Vicarious Surgical has focused on developing its platform for use in hospitals and surgical centers. The company has received U.S. Food and Drug Administration Breakthrough Device designation for its technology, but its system remains subject to regulatory review and commercialization requirements. Adam Sachs, a co-founder, has served as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RBOT Stock News HeadlinesSS Innovations names Sarah Romano as CFOJuly 15, 2026 | finance.yahoo.comVicarious Surgical board proposes dissolving the companyJuly 15, 2026 | finance.yahoo.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.September 23 at 1:00 AM | InvestorPlace (Ad)Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical SettingMay 13, 2026 | globenewswire.comVicarious Surgical Reports First Quarter 2026 Financial ResultsApril 30, 2026 | globenewswire.comVicarious Surgical Shareholders Approve Reverse Stock Split AuthorizationApril 8, 2026 | tipranks.comVicarious Surgical, Inc. Class AApril 7, 2026 | edition.cnn.comVicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia RepairMarch 30, 2026 | globenewswire.comSee More Headlines RBOT Stock Analysis - Frequently Asked Questions How have RBOT shares performed this year? Vicarious Surgical's stock was trading at $2.16 at the beginning of 2026. Since then, RBOT stock has decreased by 97.9% and is now trading at $0.0445. How were Vicarious Surgical's earnings last quarter? Vicarious Surgical Inc. (NYSE:RBOT) announced its quarterly earnings data on Monday, March, 9th. The company reported ($1.65) earnings per share for the quarter, missing the consensus estimate of ($1.37) by $0.28. When did Vicarious Surgical's stock split? Shares of Vicarious Surgical reverse split on Thursday, June 13th 2024.The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Vicarious Surgical? Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Vicarious Surgical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Aktis Oncology (AKTS), Advanced Micro Devices (AMD), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM) and SoFi Technologies (SOFI). Company Calendar Last Earnings3/09/2026Today9/23/2026Next Earnings (Estimated)11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (10m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 RBOT's financial health is in the Red zone, according to TradeSmith. RBOT has been in this zone for over 10 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:RBOT CIK1812173 Webwww.vicarioussurgical.com Phone617 868 1700FaxN/AEmployees210Year Founded2014Profitability EPS (Trailing Twelve Months)($6.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$63.22 million Net MarginsN/A Pretax MarginN/A Return on Equity-184.13% Return on Assets-112.50% Debt Debt-to-Equity RatioN/A Current Ratio4.75 Quick Ratio4.75 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$7.89 per share Price / Book0.01Miscellaneous Outstanding Shares7,124,000Free Float5,894,000Market Cap$284.96 thousand OptionableNo Data Beta1.86 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NYSE:RBOT) was last updated on 9/23/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
